Eiko LifeSciences Limited (BOM:540204)
India · Delayed Price · Currency is INR 45.63
-0.27 (-0.59%)
At close: Sep 11, 2026
Eiko LifeSciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 655 | 754 | 674 | 717 | 636 | 403 | |
Market Cap Growth | -10.02% | 11.94% | -5.99% | 12.74% | 57.59% | 33.32% |
Enterprise Value | 576 | 690 | 647 | 676 | 680 | 398 |
Last Close Price | 45.63 | 49.74 | 52.33 | 51.70 | 66.24 | 42.03 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 13.94 | 16.77 | 31.99 | 95.35 | 82.68 | 57.15 |
PS Ratio | 1.11 | 1.43 | 1.79 | 2.57 | 3.47 | 1.59 |
PB Ratio | 0.94 | 1.08 | 1.18 | 1.41 | 2.16 | 1.41 |
P/TBV Ratio | 0.95 | 1.10 | 1.19 | 1.41 | 2.16 | 1.41 |
P/FCF Ratio | 29.09 | 33.51 | - | - | 15.89 | - |
P/OCF Ratio | 29.09 | 33.51 | 24.23 | - | 15.05 | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.98 | 1.31 | 1.72 | 2.42 | 3.71 | 1.57 |
EV/EBITDA Ratio | 7.19 | 9.44 | 23.42 | 41.90 | 71.21 | 30.27 |
EV/EBIT Ratio | 8.32 | 10.97 | 31.96 | 71.12 | 211.29 | 52.86 |
EV/FCF Ratio | 25.61 | 30.65 | - | - | 17.00 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.05 | - | 0.00 | 0.16 |
Debt / EBITDA Ratio | 0.60 | 0.65 | 1.00 | - | 0.06 | 3.52 |
Debt / FCF Ratio | - | 2.10 | - | - | 0.01 | - |
Net Debt / Equity Ratio | -0.13 | -0.13 | -0.16 | -0.26 | -0.02 | 0.15 |
Net Debt / EBITDA Ratio | -1.12 | -1.22 | -3.27 | -8.27 | -0.58 | 3.35 |
Net Debt / FCF Ratio | - | -3.95 | 1.20 | 1.80 | -0.14 | -0.56 |
Asset Turnover | - | 0.68 | 0.63 | 0.67 | 0.56 | 0.99 |
Inventory Turnover | - | 8.50 | 7.16 | 11.84 | 5.06 | 8.19 |
Quick Ratio | - | 2.20 | 3.60 | 17.60 | 6.44 | 0.80 |
Current Ratio | - | 3.08 | 5.25 | 20.56 | 7.76 | 2.24 |
Return on Equity (ROE) | - | 8.40% | 4.31% | 1.88% | 2.65% | 3.43% |
Return on Assets (ROA) | - | 5.05% | 2.13% | 1.42% | 0.61% | 1.83% |
Return on Invested Capital (ROIC) | 8.42% | 8.63% | 3.59% | 2.19% | 0.78% | 2.76% |
Return on Capital Employed (ROCE) | - | 8.50% | 3.40% | 1.90% | 1.10% | 2.60% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 7.47% | 5.96% | 3.13% | 1.05% | 1.21% | 1.75% |
FCF Yield | 3.44% | 2.98% | -11.15% | -10.36% | 6.29% | -19.54% |
Buyback Yield / Dilution | -12.31% | -7.95% | -26.37% | -5.41% | -25.30% | -104.48% |
Total Shareholder Return | -12.31% | -7.95% | -26.37% | -5.41% | -25.30% | -104.48% |